These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19601885)

  • 1. HIV/AIDS: recent advances in antiretroviral agents.
    Nikolopoulos G; Bonovas S; Tsantes A; Sitaras NM
    Mini Rev Med Chem; 2009 Jul; 9(8):900-10. PubMed ID: 19601885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
    Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
    Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches toward anti-HIV chemotherapy.
    De Clercq E
    J Med Chem; 2005 Mar; 48(5):1297-313. PubMed ID: 15743172
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains.
    Chrysostomou AC; Topcu C; Stylianou DC; Hezka J; Kostrikis LG
    Infect Genet Evol; 2020 Jul; 81():104243. PubMed ID: 32061896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly approved integrase inhibitors for clinical treatment of AIDS.
    Gu WG
    Biomed Pharmacother; 2014 Oct; 68(8):917-21. PubMed ID: 25451165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New agents for the inhibition of HIV replication.
    Miles S
    HIV Clin Trials; 2000; 1(2):29-30. PubMed ID: 11590496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reverse transcriptase inhibitors, protease inhibitors].
    Tachikawa N
    Nihon Rinsho; 2012 Apr; 70(4):579-95. PubMed ID: 22568138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting chemokine receptors for HIV: past, present and future.
    Fricker SP
    Future Med Chem; 2015; 7(17):2311-5. PubMed ID: 26627446
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-drug resistant HIV-1.
    Omrani AS; Pillay D
    J Infect; 2000 Jul; 41(1):5-11. PubMed ID: 10942635
    [No Abstract]   [Full Text] [Related]  

  • 13. The development of anti-HIV-1 drugs.
    Lu XF; Chen ZW
    Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer antiretroviral agents and how to use them.
    Kim HH; Daar ES
    Curr HIV/AIDS Rep; 2009 May; 6(2):55-62. PubMed ID: 19358775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy.
    Grande F; Occhiuzzi MA; Rizzuti B; Ioele G; De Luca M; Tucci P; Svicher V; Aquaro S; Garofalo A
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets for antiretroviral therapy: clinical progress to date.
    Dau B; Holodniy M
    Drugs; 2009; 69(1):31-50. PubMed ID: 19192935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?
    Garbelli A; Riva V; Crespan E; Maga G
    Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiretroviral drugs.
    Hanson K; Hicks C
    Curr HIV/AIDS Rep; 2006 Jul; 3(2):93-101. PubMed ID: 16608666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome.
    Barbaro G; Scozzafava A; Mastrolorenzo A; Supuran CT
    Curr Pharm Des; 2005; 11(14):1805-43. PubMed ID: 15892677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists.
    Hughes A; Barber T; Nelson M
    J Infect; 2008 Jul; 57(1):1-10. PubMed ID: 18556070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.